Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy

Predicting the prognosis and adverse events (AEs) of nivolumab therapy for recurrent esophageal cancer is very important. The present study investigated whether a simple blood biochemical examination could be used to predict prognosis and AEs following nivolumab treatment for relapse of esophageal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Hiroyuki, Shiozaki, Atsushi, Fujiwara, Hitoshi, Konishi, Hirotaka, Kiuchi, Jun, Ohashi, Takuma, Shimizu, Hiroki, Arita, Tomohiro, Yamamoto, Yusuke, Morimura, Ryo, Kuriu, Yoshiaki, Ikoma, Hisashi, Kubota, Takeshi, Okamoto, Kazuma, Otsuji, Eigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219019/
https://www.ncbi.nlm.nih.gov/pubmed/35765281
http://dx.doi.org/10.3892/ol.2022.13377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219019/
https://www.ncbi.nlm.nih.gov/pubmed/35765281
http://dx.doi.org/10.3892/ol.2022.13377

Ejemplares similares